NCT01457001

Brief Summary

Multicentric randomized Italian clinical trial, open label, not for profit. To evaluate the efficacy of 25-OH-D vitamin in terms of myocardial infarction, stroke, sudden death, death for other causes in chronic haemodialysis patients. Two arms of treatment: 25-OH-D vitamin per os versus no treatment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
284

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Nov 2012

Typical duration for phase_3

Geographic Reach
1 country

28 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 13, 2011

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 21, 2011

Completed
1 year until next milestone

Study Start

First participant enrolled

November 1, 2012

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

December 1, 2016

Status Verified

November 1, 2016

Enrollment Period

4 years

First QC Date

October 13, 2011

Last Update Submit

November 30, 2016

Conditions

Keywords

chronic haemodialysis25-OH-D vitamin

Outcome Measures

Primary Outcomes (3)

  • Vital status

    Death for all causes but traumatic.

    During the follow up, every three months for three years

  • Onset of non fatal myocardial infarction

    Cumulative with the vital status

    During the follow up, every three months for three years

  • Onset of non fatal stroke

    Cumulative with the vital status

    During the follow up, every three months for three years

Secondary Outcomes (12)

  • fatal myocardial infarction

    During the follow up, every three months for three years

  • non fatal myocardial infarction

    During the follow up, every three months for three years

  • fatal stroke

    During the follow up, every three months for three years

  • non fatal stroke

    During the follow up, every three months for three years

  • sudden death

    During the follow up, every three months for three years

  • +7 more secondary outcomes

Study Arms (2)

25-OH-D vitamin

EXPERIMENTAL
Drug: 25-OH-D vitamin

control

NO INTERVENTION

Interventions

25-OH-D vitamin

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age \>= 18 years
  • hematic PTH level twofold-ninefold the upper limit
  • hematic level of 25-OH-D vitamin \< 30 ng/ml

You may not qualify if:

  • renal transplant or peritoneal dialysis less than 3 years ago
  • pregnancy
  • breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (28)

Ospedale "A. Landolfi"

Solofra, Avellino, 83029, Italy

Location

UOC Nefrologia e Dialisi - AO Moscati

Avellino, AV, 83100, Italy

Location

Ospedale Miulli

Acquaviva delle Fonti, Bari, 700021, Italy

Location

Ospedale Umberto I

Altamura, Bari, 70022, Italy

Location

Ospedale Santa Maria degli Angeli

Putignano, Bari, 70017, Italy

Location

U.O.C. Nefrologia e Dialisi - PO Beato Angelico

Acri, CS, 87041, Italy

Location

Presidio Ospedaliero Anagni

Anagni, Frosinone, 03012, Italy

Location

P.O.N.S Bonaria

San Gavino Monreale, Medio Campidano, 09037, Italy

Location

Ospedale Civile di Alghero ASL n°1

Alghero, Sassari, 07041, Italy

Location

Ospedale Civile

Manduria, Taranto, 74024, Italy

Location

P.O. Atri - Asl Teramo

Atri, Teramo, 64032, Italy

Location

SC Nefrologia e Dialisi - Ospedale Martini

Torino, TO, 10141, Italy

Location

Azienda Ospedaliera Gaetano Rummo

Benevento, 82100, Italy

Location

AORN Sant'Anna e San Sebastiano Caserta

Caserta, 81100, Italy

Location

A.O. Istituti Ospedalieri di Cremona

Cremona, 26100, Italy

Location

Ospedale S.Giovanni di Dio

Florence, 50143, Italy

Location

Azienda Ospedaliera Universitaria OO.RR Foggia

Foggia, 71100, Italy

Location

Ospedale ICOT

Latina, 04100, Italy

Location

Università di Messina

Messina, 98100, Italy

Location

Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte

Messina, 98158, Italy

Location

1° Divisione di Nefrologia - Azienda Universitaria Policlinico

Napoli, 80131, Italy

Location

Reparto di Nefrologia - Ospedale Cardarelli

Napoli, 80131, Italy

Location

Ospedale Santa Maria del Popolo degli Incurabili

Napoli, 80138, Italy

Location

ARNAS "Civico, Di Cristina"

Palermo, 90100, Italy

Location

A.O. Ospedali Riuniti Marche Nord-Presidio San Salvatore

Pesaro, 61121, Italy

Location

AO Universitaria Pisana Presidio di Cisanello

Pisa, 56126, Italy

Location

Ospedale G.B Grassi

Roma, 00122, Italy

Location

Ospedale di Belcolle

Viterbo, 01100, Italy

Location

Related Publications (1)

  • Morrone L, Palmer SC, Saglimbene VM, Perna A, Cianciolo G, Russo D, Gesualdo L, Natale P, Santoro A, Mazzaferro S, Cozzolino M, Cupisti A, Di Luca M, Di Iorio B, Strippoli GFM; Mineral Metabolism Study Group of the Italian Society of Nephrology. Calcifediol supplementation in adults on hemodialysis: a randomized controlled trial. J Nephrol. 2022 Mar;35(2):517-525. doi: 10.1007/s40620-021-01104-z. Epub 2021 Jun 26.

Related Links

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Luigi Morrone, MD

    Società Italiana di Nefrologia

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 13, 2011

First Posted

October 21, 2011

Study Start

November 1, 2012

Primary Completion

November 1, 2016

Study Completion

November 1, 2016

Last Updated

December 1, 2016

Record last verified: 2016-11

Locations